Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

868 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Calcium channel blocker and Rho-associated kinase activity in patients with hypertension.
Hata T, Soga J, Hidaka T, Idei N, Fujii Y, Fujimura N, Mikami S, Maruhashi T, Kihara Y, Chayama K, Kato H, Noma K, Liao JK, Higashi Y; ROCK Study Group. Hata T, et al. Among authors: hidaka t. J Hypertens. 2011 Feb;29(2):373-9. doi: 10.1097/HJH.0b013e328340902d. J Hypertens. 2011. PMID: 21063203 Free PMC article. Clinical Trial.
Mineralocorticoid receptor blocker eplerenone improves endothelial function and inhibits Rho-associated kinase activity in patients with hypertension.
Fujimura N, Noma K, Hata T, Soga J, Hidaka T, Idei N, Fujii Y, Mikami S, Maruhashi T, Iwamoto Y, Kihara Y, Chayama K, Kato H, Liao JK, Higashi Y; ROCK Study Group. Fujimura N, et al. Among authors: hidaka t. Clin Pharmacol Ther. 2012 Feb;91(2):289-97. doi: 10.1038/clpt.2011.227. Epub 2011 Dec 28. Clin Pharmacol Ther. 2012. PMID: 22205191 Free PMC article. Clinical Trial.
Measurement of Rho-associated kinase (ROCK) activity in humans: validity of leukocyte p-MBS/t-MBS in comparison with vascular response to fasudil.
Hata T, Goto C, Soga J, Hidaka T, Fujii Y, Idei N, Fujimura N, Maruhashi T, Mikami S, Kihara Y, Chayama K, Noma K, Liao JK, Higashi Y. Hata T, et al. Among authors: hidaka t. Atherosclerosis. 2011 Jan;214(1):117-21. doi: 10.1016/j.atherosclerosis.2010.10.005. Epub 2010 Oct 12. Atherosclerosis. 2011. PMID: 21035804 Free PMC article.
Rho-associated kinase activity, endothelial function, and cardiovascular risk factors.
Soga J, Noma K, Hata T, Hidaka T, Fujii Y, Idei N, Fujimura N, Mikami S, Maruhashi T, Kihara Y, Chayama K, Kato H, Liao JK, Higashi Y; ROCK Study Group. Soga J, et al. Among authors: hidaka t. Arterioscler Thromb Vasc Biol. 2011 Oct;31(10):2353-9. doi: 10.1161/ATVBAHA.111.227892. Epub 2011 Jul 7. Arterioscler Thromb Vasc Biol. 2011. PMID: 21737782 Free PMC article.
Rho-associated kinase activity is a predictor of cardiovascular outcomes.
Kajikawa M, Noma K, Maruhashi T, Mikami S, Iwamoto Y, Iwamoto A, Matsumoto T, Hidaka T, Kihara Y, Chayama K, Nakashima A, Goto C, Liao JK, Higashi Y. Kajikawa M, et al. Among authors: hidaka t. Hypertension. 2014 Apr;63(4):856-64. doi: 10.1161/HYPERTENSIONAHA.113.02296. Epub 2013 Dec 30. Hypertension. 2014. PMID: 24379190 Free PMC article.
Effect of aldosterone-producing adenoma on endothelial function and Rho-associated kinase activity in patients with primary aldosteronism.
Matsumoto T, Oki K, Kajikawa M, Nakashima A, Maruhashi T, Iwamoto Y, Iwamoto A, Oda N, Hidaka T, Kihara Y, Kohno N, Chayama K, Goto C, Aibara Y, Noma K, Liao JK, Higashi Y. Matsumoto T, et al. Among authors: hidaka t. Hypertension. 2015 Apr;65(4):841-8. doi: 10.1161/HYPERTENSIONAHA.114.05001. Epub 2015 Jan 26. Hypertension. 2015. PMID: 25624340 Free PMC article.
868 results